SOX4 and cancer: In a triple-negative breast cancer (TNBC) model, SOX4 enables the induction of the resistance of cancer cells to cytotoxic T cells through regulating several innate and adaptive immune pathways, including the suppression of IFNI-stimulated genes and MHC class I pathway genes (HLA-A, HLA-B, and TAP1) [151].